Vident Investment Advisory’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,379
Closed -$251K 1246
2021
Q3
$251K Buy
2,379
+202
+9% +$29K 0.01% 1041
2021
Q2
$385K Hold
2,177
0.01% 899
2021
Q1
$290K Sell
2,177
-877
-29% -$136K 0.01% 915
2020
Q4
$413K Sell
3,054
-10
-0.3% -$1.02K 0.02% 762
2020
Q3
$255K Sell
3,064
-4,431
-59% -$356K 0.01% 795
2020
Q2
$615K Buy
7,495
+221
+3% +$15K 0.03% 598
2020
Q1
$375K Sell
7,274
-1,922
-21% -$100K 0.02% 633
2019
Q4
$382K Buy
9,196
+2,693
+41% +$99.4K 0.02% 616
2019
Q3
$210K Buy
+6,503
New +$223K 0.02% 443

Other funds holding ZLAB

Vident Investment Advisory's ZLAB Position: Q4 2021 in Review

Vident Investment Advisory sold out of Zai Lab (ZLAB) in Q4 2021, closing a stake of 2,379 shares — an estimated $251K sold.

Vident Investment Advisory first reported a position in ZLAB in Q3 2019 and held it in 9 quarters. The position peaked at $615K in Q2 2020. 206 funds tracked by Wall St. Rank hold ZLAB as of Q4 2021.

  • Vident Investment Advisory reported no remaining Zai Lab position as of Q4 2021 after selling out during the quarter.
  • Vident Investment Advisory sold 2,379 Zai Lab shares in Q4 2021, an estimated $251K.
  • Vident Investment Advisory first reported a position in Zai Lab in Q3 2019 and held it in 9 quarters.
  • Vident Investment Advisory's Zai Lab position peaked at $615K in Q2 2020.
  • 206 funds tracked by Wall St. Rank held Zai Lab as of Q4 2021.

Based on Vident Investment Advisory's 13F filing for Q4 2021, filed 14 Feb 2022.